Gentle IVF, also called mild stimulation IVF or mini IVF, is an approach to in vitro fertilization that uses lower doses of fertility medications to produce fewer but potentially high-quality eggs. Where conventional IVF aims to retrieve as many eggs as possible (typically 8 to 15), gentle IVF intentionally limits stimulation and often yields fewer than that. The core idea is that more eggs don’t necessarily mean better outcomes, and that a lighter medication load can be easier on your body while still giving you a real shot at pregnancy.
How It Differs From Conventional IVF
The main difference comes down to medication. In conventional IVF, daily hormone injections typically exceed 150 IU of gonadotropins, sometimes reaching 300 IU or more, to push the ovaries into producing a large batch of follicles. Gentle IVF caps that daily dose at 150 IU or lower. The American Society for Reproductive Medicine defines “mild ovarian stimulation” as 150 IU or less of gonadotropins per day, with or without oral compounds.
Gentle IVF protocols also lean more heavily on oral medications like clomiphene citrate or aromatase inhibitors, sometimes using them in place of injections entirely or combining a low dose of injectable hormones with an oral agent. Some protocols delay starting injections until mid-cycle, around day 5 or later, rather than beginning on day 2 or 3. This shorter window of stimulation means fewer total days of medication and fewer injections overall.
The result is fewer eggs at retrieval and fewer embryos to work with. But research consistently shows that the proportion of high-quality embryos is no different between mild and conventional stimulation. In studies across poor responders, normal responders, and high responders, the percentage of top-grade embryos remained comparable regardless of how aggressively the ovaries were stimulated.
Embryo Quality and Genetic Health
One of the most common concerns about retrieving fewer eggs is whether those eggs will be chromosomally normal. A study comparing minimal stimulation to high-dose protocols found that the rate of genetically normal (euploid) embryos was nearly identical: 35.4% in the minimal stimulation group versus 37.4% in the high-dose group. That difference was not statistically significant. In other words, pumping the ovaries with higher doses of hormones did not improve the genetic health of the resulting embryos.
This matters because chromosomal abnormalities are the single biggest reason embryos fail to implant or result in early miscarriage. If the rate of normal embryos per batch is the same regardless of stimulation intensity, the advantage of conventional IVF comes mainly from volume: more embryos means more chances to find a good one. Gentle IVF trades that volume for a lighter treatment experience, which is a tradeoff worth understanding before you choose.
Success Rates Compared to Conventional IVF
Live birth rates for gentle IVF are close to those of conventional IVF, though the numbers vary by age and ovarian reserve. In one large study of patients with low prognosis, the cumulative live birth rate was 21.1% for mild stimulation versus 22.0% for conventional stimulation. That difference was not statistically meaningful.
When broken down by age, the pattern held. Women under 35 had cumulative live birth rates of 35.4% with mild stimulation compared to 38.3% with conventional. Women 35 and older saw rates of 12.3% versus 14.2%. Neither gap was statistically significant. For poor responders specifically, the ASRM concluded there is fair evidence that clinical pregnancy rates are “not substantially different” between mild and conventional protocols.
These numbers reflect cumulative rates, meaning they account for fresh and frozen embryo transfers from a single retrieval cycle. Because gentle IVF produces fewer embryos to freeze, some patients may need additional retrieval cycles to bank enough embryos, which can offset the per-cycle cost savings.
Lower Risk of Ovarian Hyperstimulation
Ovarian hyperstimulation syndrome (OHSS) is one of the most serious side effects of IVF. It happens when the ovaries overreact to fertility drugs, causing bloating, fluid buildup, and in severe cases, blood clots or kidney problems. The risk is directly tied to how much medication you receive.
Gentle IVF significantly reduces this risk. A Cochrane review found that when stimulation doses below 150 IU were used in women prone to high response, the incidence of OHSS dropped compared to conventional dosing, with no difference in live birth rates. A separate randomized trial comparing individualized dosing to conventional stimulation found that the conventional approach led to higher OHSS rates while producing the same clinical pregnancy rate. For women with polycystic ovary syndrome (PCOS), who are especially vulnerable to OHSS, this reduction in risk is particularly relevant.
Who Is a Good Candidate
Gentle IVF tends to appeal to several groups. Women with PCOS are strong candidates because their ovaries are already highly sensitive to stimulation. A meta-analysis of 31 randomized controlled trials found that minimal stimulation IVF produced similar live birth rates to conventional IVF in high responders, including PCOS patients. Choosing lower doses can spare these women a painful and potentially dangerous overstimulation episode while achieving comparable results.
Women who want to minimize the physical burden of treatment, those who’ve had side effects from high-dose protocols in previous cycles, and patients who are paying out of pocket and want to reduce medication costs are also common candidates. Some clinics recommend gentle IVF for women with diminished ovarian reserve, reasoning that their ovaries won’t produce many eggs regardless of dose, so high-dose stimulation offers little added benefit.
Gentle IVF is less ideal if you’re planning to freeze a large batch of embryos for multiple future transfer attempts, or if your clinic recommends genetic testing of embryos, which works better with a larger pool to screen from.
What the Cycle Looks Like
A gentle IVF cycle follows the same basic steps as conventional IVF, just with a lighter medication phase. The entire process from the start of stimulation to egg retrieval typically takes about two weeks. You’ll give yourself daily injections (fewer and at lower doses than conventional IVF), and some protocols replace part of the injectable medication with oral pills taken for the first several days.
Monitoring appointments start about four days after injections begin, with ultrasounds every two to three days after that to track follicle growth. Egg retrieval happens 10 to 14 days into stimulation. The retrieval procedure itself is identical to conventional IVF: a short outpatient procedure under sedation. After that, fertilization, embryo culture, and transfer proceed the same way.
Cost Differences
Conventional IVF typically costs between $15,000 and $30,000 per cycle, with medications accounting for up to 35% of that total. Because gentle IVF uses significantly less medication, the pharmacy bill is lower, sometimes by thousands of dollars. The clinic fees for monitoring, retrieval, and lab work are generally similar, so the savings come almost entirely from the drug side.
The per-cycle cost advantage is real but comes with a caveat. If gentle IVF yields only two or three embryos where conventional IVF might have produced six or eight, you may need a second retrieval cycle to have enough embryos for a reasonable chance at pregnancy. Two gentle IVF cycles can end up costing more than one conventional cycle, depending on your response. The financial math depends heavily on your age, ovarian reserve, and how many embryos you need.